TABLE 2.
Demographic data
| Total | Nontreatment‐resistant schizophrenia | Treatment‐resistant schizphrenia | |
|---|---|---|---|
| Number of patients | 2611 | 1840 | 771 |
| Age (mean ± SD) | 45.6 (±15.7) | 46.3 (±16.3) | 44.0 (±13.10) |
| Male (%) | 1118 (42.8) | 785 (42.7) | 333 (43.2) |
| Discharge | |||
| No prescription of antipsychotics (%) | 0.7 | 0.7 | 0.5 |
| Mono prescription of antipsychotic (%) | 59.8 | 58.3 | 63.3 |
| Poly prescription of antipsychotics (%) | 39.6 | 41.0 | 36.2 |
| No prescription of anxiplitic and hypnotics (%) | 35.5 | 34.8 | 37.4 |
| No prescription of antidepressants (%) | 91.5 | 90.9 | 92.2 |
| No prescription of mood stabilizers/antiepileptics (%) | 74.5 | 77.3 | 67.7 |
| No prescription of anticholinergic drugs (%) | 74.3 | 74.5 | 74.1 |
| Implementation of m‐ECT (%) | 8.1 | 3.2 | 19.8 |
| Prescription of clozapine (%) | 12.4 | 0.1 | 41.8 |
| Chlorpromazine equivalent for antipsychotics (SD) (mg/day) | 690.1 ± 427 | 642.1 ± 396.0 | 806.6 ± 472.4 |
| Biperiden equivalent for anticholinergics (SD) (mg/day) | 0.7 ± 1.5 | 0.7 ± 1.4 | 0.7 ± 1.5 |
| Imipramine equivalent for antidepressants (SD) (mg/day) | 7.5 ± 33.9 | 8.3 ± 36.2 | 5.6 ± 27.4 |
| Diazepam/nitrazepam equivalent for anxiolytics and hypnotics (SD) (mg/day) | 7.2 ± 11.8 | 7.0 ± 11.5 | 7.4 ± 12.5 |
Abbreviation: ECT: electro convulsive therapy.